Page-3 of COVID-19 vaccine
CORBEVAX’ gets DCGI approval for Clinical trials
The Drug Controller General of India (DCGI) gave approval to another indigenous COVID-19 vaccine candidate called CORBEVAX for two clinical trials. Highlights Vaccine maker Biological E received approval to conduct phase two and three clinical trials on children between five ..
Month: Current Affairs - September, 2021
India’s first mRNA-based COVID-19 vaccine
The Drugs Controller General of India (DGCI) gave nod for Phase-2 and Phase-3 trails of India’s first mRNA-based COVID-19 vaccine. Highlights First mRNA-based covid-19 vaccine, called HGCO19, is being developed by a Pune-based biotechnology company, Genova Biopharmaceuticals Ltd. The company ..
Month: Current Affairs - August, 2021
DCGI approves ZyCoV-D vaccine for Emergency Use Authorization
The Drug Controller General of India (DGCI) has approved ZyCoV-D vaccine by Zydus Cadila for Emergency Use Authorization. Key Points According to Ministry of Science and Technology, ZyCoV-D vaccine is the world’s first and India’s indigenously developed DNA-based vaccine for ..
Month: Current Affairs - August, 2021
Can Antibodies post vaccine fight Delta variant?
According to a lab study conducted in US, Delta variant of the SARS-CoV-2 virus cannot evade antibodies generated by vaccination. Key Points Findings were published in journal ‘Immunity’. It helped in explaining why vaccinated people have escaped the worst of ..
Month: Current Affairs - August, 2021
WHO’s medical alert on fake Covishield Vaccines
World Health Organisation (WHO) issued medical alerts on fake Covishield Vaccines in India. Key Points WHO has raised doubts on the genuineness of Covishield which is reaching patients in India. India is reporting circulation of fake vials of the covid-19 ..
Month: Current Affairs - August, 2021
WHO Chief Scientist: Covid vaccination is not absolute protection
Chief scientist of World Health Organisation (WHO), Dr. Soumya Swaminathan, noted that though Covid-19 vaccines may not provide absolute protection against emerging variants of the coronavirus. However, it can reduce risks of death and complications. Highlights Dr Swaminathan further emphasised ..